RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to ...

Among 47 patients with any of several forms of idiopathic inflammatory myositis (IIM) who took efgartigimod (Vyvgart Hytrulo) ...

The Business Research Company's Polymyositis Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 The Business Research Company's Latest Report Explores Market Driver ...

Polymyositis and dermatomyositis are subtypes of IIM. Polymyositis causes inflammation and weakness of the skeletal muscles responsible for movement. Dermatomyositis is a form of polymyositis that ...

ALKIVIA data demonstrate significant improvement in muscle strength and physical function in myositis patients treated with efgartigimod; RHO data show efgartigimod achieved susta ...

This rescue German Shepherd has the most expressive eyes—and the cutest permanent ‘uh-oh’ face. You’ve got to see him.

Mumbai: The government of Maharashtra has released updated Covid-19 management protocols, mandating healthcare institutions to test 5% of patients with influenza-like illness (ILI) and severe acute ...

MUMBAI, India and PRINCETON, N.J., May 30, 2025 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: ...

Dropped Head Syndrome (DHS) is a condition caused by weakness in the neck’s extensor muscles, which can lead to a forward ...

An elderly woman with chronic ulcerative colitis who developed proximal muscle weakness, increased serum creatine phosphokinase activity, and histological and electromyographic abnormalities ...